Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Familial Risk Of Cancer And Knowledge And Use Of Genetic Testing

H. Baer, P. Brawarsky, M. Murray, J. Haas
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
ABSTRACTBACKGROUNDIdentification of genetic risk factors for common diseases, including cancer, highlights the importance of familial risk assessment. Little is known about patterns of familial cancer risk in the general population, or whether this risk is associated with knowledge and use of genetic testing.OBJECTIVETo examine the distribution of familial cancer risk and its associations with genetic testing in the United States.DESIGNCross-sectional analysis of the 2005 National Health Interview Survey (NHIS).PARTICIPANTS31,428 adults who completed the NHIS Cancer Control Supplement.MAIN MEASURESFamilial cancer risk was estimated based on the number of first-degree relatives with a breast and ovarian cancer syndrome (BRCA)- or a Lynch-associated cancer, age of onset (<50 or ≥50 years), and personal history of any cancer. Outcomes included having heard of genetic testing, discussed genetic testing with a physician, been advised by a physician to have testing, and received genetic testing.KEY RESULTSMost adults (84.5%) had no family history of BRCA- or Lynch syndrome-associated cancer; 12.9% had a single first-degree relative (5.3% with early onset); and 2.7% had ≥2 first-degree relatives. Although 40.2% of adults had heard of genetic testing for cancer risk, only 5.6% of these individuals had discussed testing with a physician, and of these 36.9% were advised to be tested. Overall, only 1.4% of adults who had heard of genetic testing received a test. Familial risk was associated with higher rates of testing; 49.5% of participants in the highest risk group had heard of testing, of those 14.8% had discussed it with their physician, and 4.5% had received genetic testing.CONCLUSIONSThese nationally representative data provide estimates of the prevalence of familial cancer risk in the US and suggest that information about genetic testing is not reaching many at higher risk of inherited cancer.
This paper references
10.1001/jama.299.20.2423
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.
L. Dong (2008)
10.1056/NEJMRA012284
Breast and ovarian cancer.
R. Wooster (2003)
Genetic susceptibility to cancer. Family physicians' experience.
J. Carroll (2003)
10.7326/0003-4819-144-4-200602210-00025
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
T. Wolff (2006)
10.1097/01.GIM.0000172416.35285.9F
The state of the medical geneticist workforce: Findings of the 2003 survey of American Board of Medical Genetics certified geneticists
J. A. Cooksey (2005)
Summary health statistics for U.S. adults: National Health Interview Survey, 2005.
John R. Pleis (2006)
10.1001/jama.299.11.1320
Delivery of genomic medicine for common chronic adult diseases: a systematic review.
M. Scheuner (2008)
10.1093/FAMPRA/19.1.65
Reactions of GPs to a triage-controlled referral system for cancer genetics.
G. Elwyn (2002)
10.1097/01.GIM.0000055201.16487.61
Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature.
Sandy Suther (2003)
10.1007/978-3-642-78225-1
Colorectal Cancer
J. Hardcastle (1993)
Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
A. Ramirez (2006)
10.1097/00125817-200303000-00004
Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature
Sandy Suther (2003)
10.1016/J.CDP.2007.08.003
Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.
S. Sabatino (2007)
10.1006/PMED.2002.1022
Interest in BRCA1/2 testing in a primary care population.
K. Armstrong (2002)
10.1370/afm.60
Family Physician Self-Efficacy With Screening for Inherited Cancer Risk
R. Gramling (2004)
10.1016/S0749-3797(02)00585-8
Research priorities for evaluating family history in the prevention of common chronic diseases.
P. Yoon (2003)
10.1093/OXFORDJOURNALS.BMB.A072915
Genetics of breast and ovarian cancer.
S. Narod (1994)
10.1006/PMED.1999.0610
Likelihood of undergoing genetic testing for cancer risk: a population-based study.
K. Bosompra (2000)
10.7326/0003-4819-137-7-200210010-00012
The Genetics of Colorectal Cancer
P. Calvert (2002)
10.1097/01.gim.0000237867.34011.12
Population-based study of the prevalence of family history of cancer: Implications for cancer screening and prevention
S. Ramsey (2006)
10.1016/J.AMEPRE.2004.05.003
Cancer risk assessment: quality and impact of the family history interview.
H. Murff (2004)
10.1111/j.1525-1497.2004.30401.x
Reconsidering the family history in primary care
Eugene C. Rich (2007)
10.1097/00001888-200008000-00021
Knowledge, Attitudes, and Behaviors of Alabama's Primary Care Physicians Regarding Cancer Genetics
R. Acton (2000)
Awareness of family health history as a risk factor for disease--United States, 2004.
(2004)
10.1046/J.1525-1500.1999.00065.X
A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites.
J. Mouchawar (1999)
10.1097/00125817-200207000-00009
Can family history be used as a tool for public health and preventive medicine?
P. Yoon (2002)
10.1038/sj.bjc.6603897
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care
J. Emery (2007)
Two physician styles of focusing on the family.
J. Medalie (2000)
10.1200/JCO.2006.07.2462
Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer.
L. Acheson (2006)
10.1016/j.amepre.2009.07.021
Racial and ethnic disparities in awareness of genetic testing for cancer risk.
J. Pagán (2009)
10.1093/annonc/mdn527
Age of onset in familial cancer.
A. Brandt (2008)
Summary health statistics for U.S. adults: National Health Interview Survey, 1997.
D. Blackwell (2002)
Developing Family Healthware, a Family History Screening Tool to Prevent Common Chronic Diseases
P. Yoon (2009)
10.1159/000078162
Awareness of Genetic Testing for Increased Cancer Risk in the Year 2000 National Health Interview Survey
L. Wideroff (2003)
10.1034/j.1399-0004.2003.00112.x
Who gets the information about genetic testing for cancer risk? The role of race/ethnicity, immigration status, and primary care clinicians
Keiko Honda (2003)
10.1007/s11606-009-1009-6
Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization
D. Levy (2009)
10.1159/000160667
Family History Questionnaires Designed for Clinical Use: A Systematic Review
G. Reid (2008)
10.1016/J.YPMED.2005.10.004
Genetic testing for colon cancer among African-Americans in North Carolina.
J. Satia (2006)
10.1093/FAMPRA/18.2.135
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases.
A. Lucassen (2001)



This paper is referenced by
10.1007/s11606-014-2768-2
Accuracy of Ovarian and Colon Cancer Risk Assessments by U.S. Physicians
L. Baldwin (2014)
10.1007/s11764-013-0301-y
Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors
H. Hamann (2013)
10.1038/gim.2015.179
Expanding the genetic counseling workforce: program directors’ views on increasing the size of genetic counseling graduate programs
V. Pan (2016)
10.1007/s10897-012-9553-3
Acceptance of Genetic Counseling and Testing in a Hospital-Based Series of Patients with Gynecological Cancer
N. Dekker (2012)
10.1097/01.NPR.0000515425.45908.af
Evaluation of a new genetic family history screening questionnaire for identifying Lynch syndrome
D. Harrison (2017)
10.1257/AER.103.2.804
Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease: Corrigendum.
E. Oster (2016)
10.1038/gim.2013.75
A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians
M. Scheuner (2014)
10.1002/cam4.1864
Painting a portrait: Analysis of national health survey data for cancer genetic counseling
Monica H Stamp (2019)
10.1177/0272989X14565820
Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample
S. Knight (2015)
10.3386/w17629
Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease
Emily F. Oster (2011)
10.1016/j.amepre.2017.10.015
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
L. Hull (2018)
10.1186/s12909-017-0982-4
Increasing confidence and changing behaviors in primary care providers engaged in genetic counselling
M. Wilkes (2017)
Communication about genetic testing and hereditary cancer management with breast and ovarian cancer patients
C. Jacobs (2018)
10.1017/9781108687232
The Biopolitics of Intellectual Property: Regulating Innovation and Personhood in the Information Age
Gordon Hull (2020)
Communication of Lynch Syndrome Genetic Test Results: Strategies to Facilitate Information Sharing with At-risk Family Members
Tara Biagi (2011)
10.3390/jpm9020026
Exploring Predictors of Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer: Findings from the 2015 U.S. National Health Interview Survey
C. Allen (2019)
10.1007/s13187-014-0643-9
From Observation to Intervention: Development of a Psychoeducational Intervention to Increase Uptake of BRCA Genetic Counseling Among High-Risk Breast Cancer Survivors
S. Vadaparampil (2014)
10.1007/s11606-012-1988-6
The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine
Eric A. Feldman (2012)
10.1111/j.1524-4741.2012.01274.x
Genetic Determinants of Breast Cancer Risk: A Review of Current Literature and Issues Pertaining to Clinical Application
U. O. Njiaju (2012)
10.1007/s13277-016-5168-x
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures
O. Golubnitschaja (2016)
Communication of Lynch Syndrome Genetic Test Results: Strategies to Facilitate Information Sharing with At-risk Family Members
Ann Jeffers-Brown (2011)
In Search of New Perspectives in Cancer Genetics Services: Exploring Use of Genetic Counseling Among a Group of Young Breast Cancer Survivors
Cheryl Lee (2018)
10.1007/s11606-014-3113-5
Impact of a Randomized Controlled Educational Trial to Improve Physician Practice Behaviors Around Screening for Inherited Breast Cancer
R. Bell (2014)
10.1007/s11606-016-3943-4
Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda
M.P.H. Jada G. Hamilton Ph.D. (2016)
10.1038/gim.2014.68
Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system
Cecelia A. Bellcross (2015)
10.1186/s12885-019-5312-2
Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population
L. Gallardo-Alvarado (2019)
10.1016/J.JEMEP.2017.08.001
The subject and power of bioethics
Gordon Hull (2017)
10.1515/fhep-2013-0011
The Economics of Personalization in Prevention and Public Health
Don Kenkel (2013)
10.1188/11.CJON.330-332
Genetic information and discrimination: a policy analysis.
Cindy Snyder (2011)
A descriptive study of the genetic counseling environment of men with breast cancer in the United States
Elizabeth Hight (2013)
10.1007/s12687-012-0090-4
Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral
E. V. Riel (2012)
10.1007/s11606-016-3943-4
Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda
J. Hamilton (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar